Seeking Alpha

Mela Sciences (MELA) +9.5% - but down from +19% - after the FDA OKs the firm's MelaFind device...

Mela Sciences (MELA) +9.5% - but down from +19% - after the FDA OKs the firm's MelaFind device for detecting melanoma. The approval follows a 2.5-year attempt and is expected to allow doctors to signficantly reduce the number of invasive biopsies.
Comments (1)
  • jrusso9722
    , contributor
    Comments (94) | Send Message
     
    Melanoma, the "skin cancer", which can penetrate and destroy a person's body. It destroys families too, worry, anxiety, depression, as loved ones suffer. Now, we have a weapon, at it's most advantageous, early detection. Congratulations to the millions across the world who will live longer, happier lives, by having melanoma detected and removed, early.
    3 Nov 2011, 06:58 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|